Abstract
Hepatocellular adenoma is one of the benign tumors which may occur in the liver. Solitary adenoma is more frequent in women, especially associated with the use of oral contraceptives or anabolic steroids. Glycogen storage disease and mutation of HNF1A gene are associated with an increased incidence of adenomas. It is usually asymptomatic and found incidentally. MRI is used to suspect the diagnosis which should be confirmed by liver biopsy. Recently, adenomas have been usually divided in four types with different characteristics (Bordeaux classification): adenoma with HFN1A gene mutation, adenoma with B-catenin gene mutation, adenoma without any markers, and inflammatory adenomas. It has been reported with an increasing risk of bleeding (up to 25 %) or tumor transformation (up to 9 %) based on histologic classification (B-catenin mutation) and size. Surgical resection is usually recommended in case of tumor size larger than 5 cm, B-catenin mutation, presence of symptoms, evidence of dysplasia or atypia at the biopsy, or features of malignant transformation (increase size at the follow-up). Early postoperative outcome after partial hepatectomy has been reported excellent as well as long-term results. In case of adenomatosis (more than ten adenoma), surgical resection of the greatest lesions may be recommended; however, liver transplantation may be considered in case of diffuse disease, and it has been reported as an exceptional indication in 0.09 % of all indications in the world.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Flejou JF, Barge J, Menu Y et al (1985) Liver adenomatosis: an entity distinct from liver adenoma? Gastroenterology 89:1132–1138
Farges O, Ferreira N, Dokmak S et al (2011) Changing trends in malignant transformation of hepatocellular adenoma. Gut 60:85–89
Jeannot E, Wendum D, Paye F, Mourra N, de Toma C, Flejou JF, Zucman-Rossi J (2006) Hepatocellular adenoma displaying a HNF1alpha inactivation in a patient with familial adenomatous polyposis coli. J Hepatol 45(6):883–886
Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW (1979) Epidemiology of hepatocellular adenoma. The role of oral contraceptives. JAMA 242(7):644–648
Lin H, Van den Esschert J, Liu C, Van Gulik T (2011) Systematic review of hepatocellular adenoma in China and other regions. J Gastroenterol Hepatol 26:28–35
Lee PJ (2002) Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr 161(Suppl 1):S46–S49
Steinbrecher UP, Lisbona R, Huang SN, Mishikin S (1981) Complete regression of hepatocellular adenoma after withdrawal of oral contraceptives. Dig Dis Sci 26(11):1045–1050
Torbeson M, Lee JH, Choti M, Gage W, Abraham SC, Montgomery E, Boitnott J, Wu TT (2002) Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signalling pathway. Mod Pathol 15(3):189–196
Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M (1997) Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 24(3):276–279
Demo E, Frush D, Gottfried M, Koepke J, Boney A, Bali D, Chen YT, Kishnani PS (2007) Glycogen storage disease type III-hepatocellular carcinoma a long term complication? J Hepatol 46(3):492–498
Bannasch P, Mayer D, Hacker HJ (1980) Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim Biophys Acta 605(2):217–245
Pelletier L, Rebouissou S, Paris A et al (2010) Loss of HNF1αfunction in human hepatocellular adenomas leads to aberrant activation os signaling pathways involved in tumorigenesis. Hepatology 51:557–566
Rebouissou S, Amessou M, Couchy G, Poussin K, Imbeaud S, Pilati C et al (2009) Frequent inframe somatic deletion activate gp130 in inflammatory hepatocellular tumors. Nature 57:200–204
Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S et al (2006) Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 43:515–524
Bioulac-Sage P, Rebouissou S, Thomas C, Blanc JF, Saric J et al (2007) Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology 46:740–748
Bioulac-Sage P, Laumonier H, Couchy G, Le Bail B et al (2009) Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience. Hepatology 50:481–489
Cobey FC, Salem RR (2004) A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg 187:181–191
Edmondson HA, Henderson B, Benton B (1976) Liver cell adenomas associated with use of oral contraceptives. N Engl J Med 294:470–472
Kerlin P, Davis GL, McGill DB, Weiland LH et al (1983) Hepatic adenoma and focal nodular hyperplasia: clinical, pathologic and radiologic features. Gastroenterology 84:994–1002
Mathieu D, Bruneton JN, Drouillard J et al (1986) Hepatic adenomas and focal nodular hyperplasia: dynamic CT study. Radiology 160:53–58
Leese T, Farges O, Bismuth H (1988) Liver cell adenomas: a 12-year surgical experience from a specialist hepatobiliary unit. Ann Surg 208:558–564
Iwatsuki S, Todo S, Starzl TE (1990) Excisional therapy for benign hepatic lesions. Surg Gynecol Obstet 171:240–246
Arrive L, Flejou JF, Vilgrain V et al (1994) Hepatic adenoma: MR findings in 51 pathologically proved lesions. Radiology 193:507–512
Pertschy J, Ruckert JC, Manger T (1994) Diagnosis and surgical therapy of benign liver tumors. Zentralbl Chir 119:495–500
Chung J, Ferzli G, David A, Kiel T (1995) Laparoscopic resection of a large hepatic tumor. Surg Endosc 9:733–735
Nagorney DM (1995) Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 19:13–18
De Carlis L, Pirotta V, Rondinara GF et al (1997) Hepatic adenoma and focal nodular hyperplasia: diagnosis and criteria for treatment. Liver Transpl Surg 3:160–165
Ott R, Hohenberger W (1998) Focal nodular hyperplasia and liver cell adenoma: operation or observation? Zentralbl Chir 123:145–153
Closset J, Veys I, Peny MO et al (2000) Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia. Hepatogastroenterology 47:1382–1384
Ichikawa T, Federle MP, Grazioli L et al (2000) Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 214:861–868
Reddy KR, Kligerman S, Levi J et al (2001) Benign and solid tumors of the liver: relationship to sex, age, size of tumors and outcome. Am Surg 67:173–178
Terkivatan T, de Witt JH, de Man RA et al (2001) Indications and long term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 136:1033–1038
Descottes B, Glineur D, Lachachi F et al (2003) Laparoscopic liver resection of benign liver tumors. Surg Endosc 17:23–30
Toso C, Majno P, Andreas A et al (2005) Management of hepatocellular adenoma: solitary uncomplicated, multiple and ruptured tumors. World J Gastroenterol 11:5691–5695
Erdogan D, Busch OR, van Delden OM et al (2006) Management of spontaneous haemorrhage and rupture of hepatocellular adenomas. A single centre experience. Liver Int 26:433–438
Van der Windt DJ, Kok NF, Hussain SM et al (2006) Case-oriented approach to the management of hepatocellular adenoma. Br J Surg 93:1495–1502
Chaib E, Gama-Rodrigues J, Ribeiro MA et al (2007) Hepatic adenoma. Timing for surgery. Hepatogastroenterology 54:1382–1387
Koffron AJ, Auffenberg G, Kung R, Abecassis M (2007) Evaluation of 300 minimally invasive liver resections at a single institution: less is more. Ann Surg 246:385–392; discussion 92–94
Reddy SK, Kishnani PS, Sullivan JA et al (2007) Resection of hepatocellular adenoma in patients with glycogen storage disease type Ia. J Hepatol 47:658–663
Buell JF, Thomas MT, Rudich S et al (2008) Experience with more than 500 minimally invasive hepatic procedures. Ann Surg 248:475–486
Cho SW, Marsh JW, Steel J et al (2008) Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol 15:2795–2803
Petri A, Hohn J, Kokai EL et al (2008) Surgery of benign liver tumors: indications for treatment: twenty years’ experience. Hepatogastroenterology 55:592–595
Deneve JL, Pawlik TM, Cunningham S et al (2009) Liver cell adenoma management: a multicenter analysis of risk factors for rupture and malignancy. Ann Surg Oncol 16:640–648
Dokmak S, Paradis V, Vilgrain V et al (2009) A single center surgical experience of 22 patients with single and multiple hepatocellular adenomas. Gastroenterology 137:1698–1705
Mounajjed T, Wu TT (2011) Telangiectatic variant of hepatic adenoma: clinicopathologic features and correlation between liver needle biopsy and resection. Am J Surg Pathol 35:1356–1363
Bunchorntavakul C, Bahirwani R, Drazek D et al (2011) Clinical features and natural history of hepatocellular adenomas: the impact of obesity. Aliment Pharmacol Ther 34:664–667
De Angelis N, Memeo R, Calderaro J et al (2014) Open and laparoscopic resection of hepatocellular adenoma: trends over 23 years at a specialist hepatobiliary unit. HPB (Oxford) 16(9):783–788
Foster JH, Berman NN (1994) The malignant transformation of liver cell adenomas. Arch Surg 129:712–717
Lepreux S, Laurent C, Blanc JF, Trillaud H, Le Bail B et al (2003) The identification of small nodules in liver adenomatosis. J Hepatol 39:77–85
Flowers BF, McBurney RP, Vera SR (1990) Ruptured hepatic adenoma. A spectrum of presentation and treatment. Am Surg 56:380–383
Akovbiantz A, Ackermann D, Buhler H, Schmid M (1980) Management of liver cell adenoma and focal nodular hyperplasia. Helv Chir Acta 47(5):607–609
Yoshidome H, McMasters KM, Edwards M (1999) Management issues regarding hepatic adenomatosis. Am Surg 65:1070–1076
Ribeiro A, Burgart LJ, Nagorney DM, Gores GJ (1998) Management of liver adenomatosis: results with a conservative surgical approach. Liver Transpl Surg 4:388–398
Barthelmes L, Tait IS (2005) Liver cell adenoma and liver cell adenomatosis. HPB (Oxford) 7:186–196
Tepetes K, Selby R, Webb M, Madariaga JR, Iwatsuki S, Starzl TE (1995) Orthotopic liver transplantation for benign hepatic neoplasms. Arch Surg 130:153–156
Ercolani G, Grazi GL, Pinna AD (2010) Liver transplantation for benign hepatic tumors: a systematic review. Dig Surg 27:68–75
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing AG Switzerland
About this chapter
Cite this chapter
Ercolani, G., Zanfi, C., Cescon, M., Pinna, A.D. (2015). Hepatocellular Adenoma. In: Aldrighetti, L., Cetta, F., Ferla, G. (eds) Benign Tumors of the Liver. Springer, Cham. https://doi.org/10.1007/978-3-319-12985-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-12985-3_13
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12984-6
Online ISBN: 978-3-319-12985-3
eBook Packages: MedicineMedicine (R0)